SeaStar Medical Holding Corporation Common Stock (ICU)
Stock · NASDAQ · Health Care
$2.9as of 10/16/2026
Price chart
Active signals
ICU Signal Track Record
How signals performed across all stocks →What ICU's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 24 | -5.8% | 42% | October 2, 2026 |
| Bollinger Band Breakdown | 20 | -22.5% | 20% | December 19, 2025 |
| Bollinger Band Breakout | 17 | -18.6% | 29% | October 2, 2026 |
| 200-Day Moving Average TouchActive now | 5 | +0.4% | 80% | August 20, 2026 |
| Any 20-session window (baseline) | -8.4% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ICU
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUEL…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 18
- Website
- seastarmedical.com
Fundamentals
- 1-day range
- $3$3.14
- Market cap
- $12.19M
- P/E (trailing)
- —
- P/E (forward)
- -1.17
- EPS (trailing)
- $-3.93
- Dividend yield
- —
- Beta
- -1.11
- Avg. volume
- 111.0K
How SeaStar Medical Holding Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 25, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
SeaStar Medical Holding Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- ICUSeaStar Medical Holding Corporation Common Stock$2.9▼ 5.23%Market cap $12.19MP/E —$2.07$7.35
- AMIXAutonomix Medical Inc. Common Stock$2.85▼ 2.90%Market cap $11.82MP/E —$2.44$32.55
- NMTCNeuroOne Medical Technologies Corporation Common Stock$0.961▼ 7.60%Market cap $13.36MP/E —$0.9615$6.96
- MODDModular Medical Inc. Common Stock$2.32▲ 7.18%Market cap $10.99MP/E —$1.72$18.76
- ICCMIceCure Medical Ltd. Ordinary Shares$1.06▲ 1.92%Market cap $10.55MP/E —$1.04$29.46
- SINTSiNtx Technologies Inc. Common Stock$1.74▼ 1.69%Market cap $10.36MP/E —$1.4$4.5
- CODXCo-Diagnostics Inc. Common Stock$0.654▼ 8.53%Market cap $9.91MP/E —$0.746$46.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ICU SeaStar Medical Holding Corporation Common Stock | $12.19M | — | $2.9 | ▼ 5.23% | $2.07$7.35 |
| AMIX Autonomix Medical Inc. Common Stock | $11.82M | — | $2.85 | ▼ 2.90% | $2.44$32.55 |
| NMTC NeuroOne Medical Technologies Corporation Common Stock | $13.36M | — | $0.961 | ▼ 7.60% | $0.9615$6.96 |
| MODD Modular Medical Inc. Common Stock | $10.99M | — | $2.32 | ▲ 7.18% | $1.72$18.76 |
| ICCM IceCure Medical Ltd. Ordinary Shares | $10.55M | — | $1.06 | ▲ 1.92% | $1.04$29.46 |
| SINT SiNtx Technologies Inc. Common Stock | $10.36M | — | $1.74 | ▼ 1.69% | $1.4$4.5 |
| CODX Co-Diagnostics Inc. Common Stock | $9.91M | — | $0.654 | ▼ 8.53% | $0.746$46.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- SeaStar Medical Receives FDA's Medical Breakthrough Device Designation For Its Selective Cytopheretic Device Therapy To Treat Hyperinflammationbenzinga · 10/7/2026
- FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic ConditionYahoo · 10/7/2026
- SeaStar Medical Receives FDA's Medical Breakthrough Device Designation For Its Selective Cytopheretic Device Therapy To Treat HyperinflammationBenzinga · 10/7/2026
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga · 10/5/2026
- SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross ProceedsYahoo · 10/5/2026
- SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026Yahoo · 10/2/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 10/2/2026
- New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)Yahoo · 10/1/2026
- SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026Yahoo · 9/29/2026
Insider Activity
Insider Actions →- Michael Messinger · August 18, 2026 · Buy750 @ $3.27
- Eric Schlorff · July 1, 2026 · Grant10.3K
- Kevin Chung · July 1, 2026 · Grant7.2K
- Jennifer A. Baird · July 1, 2026 · Grant4.0K
- Bernadette N. Vincent · July 1, 2026 · Grant4.0K
- John Neuman · July 1, 2026 · Grant4.0K
- Van Heel Kenneth · July 1, 2026 · Grant4.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 117.5K
- Total value held
- $437.2K
- Institutional holders
- 14
- Unknown55.6K
- Unknown28.8K
- Unknown28.0K
- Unknown1.7K
- Unknown1.4K
- Unknown913
- Unknown793
- Unknown230
- Unknown22
- Unknown20
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy
SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy. SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.